openPR Logo
Press release

Lawsuit filed for Investors in shares of Stem, Inc. (NYSE: STEM) over alleged Securities Laws Violations

05-22-2023 08:13 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A lawsuit was filed on behalf of investors in Stem, Inc. (NYSE: STEM) shares over alleged securities laws violations.

A lawsuit was filed on behalf of investors in Stem, Inc. (NYSE: STEM) shares over alleged securities laws violations.

An investor, who purchased shares of Stem, Inc. (NYSE: STEM), filed a lawsuit over alleged violations of Federal Securities Laws by Stem, Inc. f/k/a Star Peak Energy Transition Corp.

Investors who purchased shares of Stem, Inc. (NYSE: STEM) have certain options and for certain investors are short and strict deadlines running. Deadline: July 11, 2023. NYSE: STEM investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

San Francisco, CA based Stem, Inc. operates as a digitally connected and intelligent energy storage network provider in the United States and internationally. On December 4, 2020 Stem, Inc. announced that it had entered into a definitive agreement to merge with Star Peak Energy Transition Corp., a special purpose acquisition corporation (known as a SPAC or blank-check company), that would result in a combined company with an estimated equity value of approximately $1.35 billion.
On February 24, 2022, Stem, Inc. announced that it had entered into a strategic partnership with Available Power ("AP") with a "[v]alue of award expected to exceed $500 million across the project portfolio" and that "provide[d] Stem exclusive rights to 100 standalone energy storage projects in Texas".
On January 11, 2023, Blue Orca Capital ("Blue Orca") issued a report alleging undisclosed issues with Stem's business and financial prospects, including, among other things, that the Company had overstated its software revenues by falsely claiming that 100% of its services revenue line was attributable to software revenues. Thereafter, on January 12, 2023, Stem issued a response, purporting to refute Blue Orca's claims. In doing so, however, the Company never expressly refuted Blue Orca's claims that software revenue did not make up 100% of the Company's services revenue. Separately, Stem's response to the Blue Orca report clarified that the Company's "canceled . . . booking of approximately $135 million in the fourth quarter of 2022" - as first disclosed in Stem's January 5, 2023 investor presentation deck - was "attributable solely to DevCo projects with [AP]" and that "[w]e have not recorded any revenue from any [AP] projects and there are no additional projects in the backlog with this former partner."
Finally, on February 16, 2023, Stem, Inc. reported its 4Q 2022 results and 2023 guidance. The Company reported 4Q revenue of $156 million, versus consensus estimates of $166 million, and issued disappointing FY 2023 revenue guidance of $550 million to $650 million.

Shares of Stem, Inc. (NYSE: STEM) declined from $18.01 per share on September 15, 2022, to as low as $3.715 per share on May 2, 2023.

The plaintiff claims that, the Offering Documents that were filed in connection with the Merger and that the Defendants between March 4, 2021 and February 16, 2023 made false and/or misleading statements and/or failed to disclose that, Legacy Stem suffered from material weaknesses in internal control over financial reporting related to accounting for deferred cost of goods sold and inventory, certain revenue recognition calculations, and internal-use capitalized software calculations;, that the Company had overstated Legacy Stem's and its own post-Merger business and financial prospects, that Stem's software revenue did not make up 100% of the Company's services revenue, that Stem had overstated the benefits expected to flow from its AP partnership, and that as a result, the Offering Documents and Defendants' public statements between March 4, 2021 and February 16, 2023 were materially false and/or misleading and failed to state information required to be stated therein.

Those who purchased shares of Stem, Inc. (NYSE: STEM) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lawsuit filed for Investors in shares of Stem, Inc. (NYSE: STEM) over alleged Securities Laws Violations here

News-ID: 3062984 • Views:

More Releases from Shareholders Foundation

Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to recover losses
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements. Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover losses
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc.. Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Malvern, PA based Ocugen, Inc., a
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) should contact the Shareholders Foundation in connection with Lawsuit
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp. Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV
Investigation announced for Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL) over possible Violations of Securities Laws
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements. Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false

All 5 Releases


More Releases for Stem

Stem Cells Market: Development of Infrastructure to Drive Global Stem Cells Mark …
In the global stem cells market a sizeable proportion of companies are trying to garner investments from organizations based overseas. This is one of the strategies leveraged by them to grow their market share. Further, they are also forging partnerships with pharmaceutical organizations to up revenues. Read Report Overview - https://www.transparencymarketresearch.com/stem-cells-market.html In addition, companies in the global stem cells market are pouring money into expansion through multidisciplinary and multi-sector collaboration for large
Global Animal Stem Cell Therapy Market Detailed Analysis 2018-2025 : MediVet Bio …
Qyresearchreports include new market research report “Global Animal Stem Cell Therapy Market Research Report 2018” to its huge collection of research reports. Animal stem cell therapy is a usage of animals stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process
Stem Cell Industry - Exclusive Interviews with Stem Cell Industry Executives
MarketResearchReports.Biz adds “Global Stem Cell Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Stem Cell and the growth estimates for the forecasted period. Stem cell research has been in process for over five decades. Stem cells have a unique ability to divide and replicate repeatedly, as well as an “unspecialized” nature that allows them to differentiate into a
Autologous Stem Cell and Non-Stem Cell Based Therapies Market
Autologous stem-cell transplantation (also known as autogeneic, autogenic, or autogenous stem-cell transplantation or auto-SCT) is the autologous transplantation of stem cells—which is, transplantation in which the undifferentiated cells or stem cells (cells from which other types of cells develop) are taken from a person, accumulated, and given back to the same person later. Even though it is most often executed by means of hematopoietic stem cells (antecedent of cells that
Global Stem Cell Storage Market By Product Type - Umbilical Cord Blood Stem Cell …
Researchmoz added Most up-to-date research on "Global Stem Cell Storage Market By Product Type - Umbilical Cord Blood Stem Cell, Embryonic Stem Cell & Adult Stem Cell" to its huge collection of research reports. In this report, the global Stem Cell Storage market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between
Stem Cell Media Sales In Global Market, 2017: By Product Type - Pluripotent Stem …
Researchmoz added Most up-to-date research on "Stem Cell Media Sales In Global Market, 2017: By Product Type - Pluripotent Stem Cell Culture, Neural Stem Cell Culture & Mesenchymal Stem Cell Culture" to its huge collection of research reports. In this report, the global Stem Cell Media market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a